Chow NH - Search Results

1

The molecular signature for urothelial carcinoma of the upper urinary tract.

Ho CL, Tzai TS, Chen JC, Tsai HW, Cheng HL, Eisenberger CF, Chow NH. Ho CL, et al. Among authors: chow nh. J Urol. 2008 Mar;179(3):1155-9. doi: 10.1016/j.juro.2007.10.026. J Urol. 2008. PMID: 18206169

2

Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation.

Cheng HL, Trink B, Tzai TS, Liu HS, Chan SH, Ho CL, Sidransky D, Chow NH. Cheng HL, et al. Among authors: chow nh. J Clin Oncol. 2002 Mar 15;20(6):1544-50. doi: 10.1200/JCO.2002.20.6.1544. J Clin Oncol. 2002. PMID: 11896103

3

Clinical significance of allelotype profiling for urothelial carcinoma.

Tzai TS, Chen HH, Chan SH, Ho CL, Tsai YS, Cheng HL, Dai YC, Lin JS, Yang WH, Chow NH. Tzai TS, et al. Among authors: chow nh. Urology. 2003 Aug;62(2):378-84. doi: 10.1016/s0090-4295(03)00344-3. Urology. 2003. PMID: 12893368

4

The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.

Tzai TS, Tsai YS, Chow NH. Tzai TS, et al. Among authors: chow nh. Urol Oncol. 2004 Mar-Apr;22(2):112-8. doi: 10.1016/S1078-1439(03)00176-5. Urol Oncol. 2004. PMID: 15082007

5

Allelic loss of 14q32 in the pathogenesis of gastrointestinal and ampullary malignancies: mapping of the target region to a 17 cM interval.

Dai YC, Ho CL, Tsai YC, Hsu YH, Chang YC, Liu HS, Chen HH, Chow NH. Dai YC, et al. Among authors: chow nh. J Cancer Res Clin Oncol. 2005 Feb;131(2):94-100. doi: 10.1007/s00432-004-0622-3. Epub 2004 Oct 21. J Cancer Res Clin Oncol. 2005. PMID: 15503134

6

The novel targets for anti-angiogenesis of genistein on human cancer cells.

Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH. Su SJ, et al. Among authors: chow nh. Biochem Pharmacol. 2005 Jan 15;69(2):307-18. doi: 10.1016/j.bcp.2004.09.025. Epub 2004 Nov 19. Biochem Pharmacol. 2005. PMID: 15627483

7

Mini chamber system for long-term maintenance and observation of cultured cells.

Ho CL, Mou TY, Chiang PS, Weng CL, Chow NH. Ho CL, et al. Among authors: chow nh. Biotechniques. 2005 Feb;38(2):267-73. doi: 10.2144/05382RR03. Biotechniques. 2005. PMID: 15727133 Free article.

8

Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract.

Tsai YS, Tzai TS, Chow NH, Wu CL. Tsai YS, et al. Among authors: chow nh. Urology. 2005 Dec;66(6):1197-202. doi: 10.1016/j.urology.2005.06.117. Urology. 2005. PMID: 16360440

9

The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma.

Tsai HW, Chow NH, Lin CP, Chan SH, Chou CY, Ho CL. Tsai HW, et al. Among authors: chow nh. Hum Pathol. 2006 Feb;37(2):198-204. doi: 10.1016/j.humpath.2005.10.012. Epub 2005 Dec 20. Hum Pathol. 2006. PMID: 16426920

10

Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.

Hsu PY, Liu HS, Cheng HL, Tzai TS, Guo HR, Ho CL, Chow NH. Hsu PY, et al. Among authors: chow nh. J Urol. 2006 Nov;176(5):2262-7. doi: 10.1016/j.juro.2006.07.048. J Urol. 2006. PMID: 17070309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters